GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome

Jacob Rabinson; Simion Meltcer; Efraim Zohav; Ofer Gemer; Eyal Y. Anteby; Raoul Orvieto

doi:10.1016/j.fertnstert.2007.03.007

GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome

Jacob Rabinson
, Simion Meltcer
, Efraim Zohav
, Ofer Gemer
, Eyal Y. Anteby
, Raoul Orvieto

Barzilai University Medical Center

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

In an attempt to examine whether body mass index (BMI) may influence IVF outcome in patients undergoing COH with either GnRH-agonist (agonist group) or GnRH-antagonist (antagonist group), we studied 799 IVF cycles: 481 in the agonist group and 318 in the antagonist group. In patients with BMI >25 kg/m², COH with either GnRH-agonist or GnRH-antagonist achieved a comparable outcome; whereas in patients with BMI <25 kg/m², the use of GnRH-agonist suppressive protocol revealed significantly higher pregnancy rates.

Original language	English
Pages (from-to)	472-474
Number of pages	3
Journal	Fertility and Sterility
Volume	89
Issue number	2
DOIs	https://doi.org/10.1016/j.fertnstert.2007.03.007
State	Published - 1 Feb 2008

ASJC Scopus subject areas

Reproductive Medicine
Obstetrics and Gynecology

Access to Document

10.1016/j.fertnstert.2007.03.007

Cite this

@article{18673210dfbd43f4861e2c47d9249290,

title = "GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome",

abstract = "In an attempt to examine whether body mass index (BMI) may influence IVF outcome in patients undergoing COH with either GnRH-agonist (agonist group) or GnRH-antagonist (antagonist group), we studied 799 IVF cycles: 481 in the agonist group and 318 in the antagonist group. In patients with BMI >25 kg/m2, COH with either GnRH-agonist or GnRH-antagonist achieved a comparable outcome; whereas in patients with BMI <25 kg/m2, the use of GnRH-agonist suppressive protocol revealed significantly higher pregnancy rates.",

author = "Jacob Rabinson and Simion Meltcer and Efraim Zohav and Ofer Gemer and Anteby, \{Eyal Y.\} and Raoul Orvieto",

year = "2008",

month = feb,

day = "1",

doi = "10.1016/j.fertnstert.2007.03.007",

language = "English",

volume = "89",

pages = "472--474",

journal = "Fertility and Sterility",

issn = "0015-0282",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - GnRH agonist versus GnRH antagonist in ovarian stimulation

T2 - the influence of body mass index on in vitro fertilization outcome

AU - Rabinson, Jacob

AU - Meltcer, Simion

AU - Zohav, Efraim

AU - Gemer, Ofer

AU - Anteby, Eyal Y.

AU - Orvieto, Raoul

PY - 2008/2/1

Y1 - 2008/2/1

N2 - In an attempt to examine whether body mass index (BMI) may influence IVF outcome in patients undergoing COH with either GnRH-agonist (agonist group) or GnRH-antagonist (antagonist group), we studied 799 IVF cycles: 481 in the agonist group and 318 in the antagonist group. In patients with BMI >25 kg/m2, COH with either GnRH-agonist or GnRH-antagonist achieved a comparable outcome; whereas in patients with BMI <25 kg/m2, the use of GnRH-agonist suppressive protocol revealed significantly higher pregnancy rates.

AB - In an attempt to examine whether body mass index (BMI) may influence IVF outcome in patients undergoing COH with either GnRH-agonist (agonist group) or GnRH-antagonist (antagonist group), we studied 799 IVF cycles: 481 in the agonist group and 318 in the antagonist group. In patients with BMI >25 kg/m2, COH with either GnRH-agonist or GnRH-antagonist achieved a comparable outcome; whereas in patients with BMI <25 kg/m2, the use of GnRH-agonist suppressive protocol revealed significantly higher pregnancy rates.

UR - https://www.scopus.com/pages/publications/38949104426

U2 - 10.1016/j.fertnstert.2007.03.007

DO - 10.1016/j.fertnstert.2007.03.007

M3 - Article

C2 - 17582402

AN - SCOPUS:38949104426

SN - 0015-0282

VL - 89

SP - 472

EP - 474

JO - Fertility and Sterility

JF - Fertility and Sterility

IS - 2

ER -

GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this